How did Blood Cancer United secure a discontinued experimental cancer drug for patients?

Blood Cancer United, a nonprofit group, purchased the remaining supply of Luvelta, an experimental blood cancer drug that had been discontinued. This rare move ensures patients relying on the drug continue receiving it after the original sponsor ended its access program, highlighting growing nonprofit roles in post-trial patient care.